FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080681938> ?p ?o ?g. }

• W2080681938 endingPage "280" @default.
• W2080681938 startingPage "275" @default.
• W2080681938 abstract "To assess the value of the serum carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and breast cancer-associated antigen CA15.3 (CEA-TPA-CA15.3) tumour marker panel in selecting from a group of patients with equivocal bone scintigraphy, chest X-ray or liver echography, those with skeletal, thoracic or liver metastases. Clinical data of 427 breast cancer patients submitted to an intensive follow-up after mastectomy between January 1986 and December 2000 were retrospectively reviewed.Among the 427 patients operated on for breast cancer, 221 patients with a total of 332 equivocal instrumental examinations (bone scintigraphy, n = 286; chest X-ray, n = 29; liver echography, n = 17) were reviewed. All 221 patients were followed up clinically, biochemically and instrumentally until there was a clear definition of their condition, metastatic or not, for an average time of 35 months. Positive and negative predictive values of the tumour marker panel in patients with equivocal bone scintigraphy, chest X-ray and liver echography were evaluated; concomitant clinical symptoms were also taken into consideration.Among the 221 patients with equivocal bone scintigraphy, chest X-ray and liver echography, tumour markers showed a positive predictive value of 69, 93 and 83% and a negative predictive value of 98, 86 and 91%, respectively, for the indication of the metastatic or benign origin of the equivocal instrumental imaging. Clinical symptoms were not helpful in predicting metastatic disease (sensitivity, specificity and accuracy of 60, 53 and 54%, respectively).These data suggest that a short monitoring with the CEA-TPA-CA15.3 tumour marker panel is an important tool to confirm or exclude metastatic disease in those patients who are suspected to have metastases following common instrumental investigations, and it is particularly important to avoid false positive diagnoses." @default.
• W2080681938 created "2016-06-24" @default.
• W2080681938 creator A5030190878 @default.
• W2080681938 creator A5056157710 @default.
• W2080681938 creator A5074072927 @default.
• W2080681938 creator A5081012227 @default.
• W2080681938 date "2003-01-01" @default.
• W2080681938 modified "2023-09-25" @default.
• W2080681938 title "Utility of a Serum Tumour Marker Panel in the Post-Operative Follow-Up of Breast Cancer Patients with Equivocal Conventional Radiological Examinations" @default.
• W2080681938 cites W1601599130 @default.
• W2080681938 cites W1848441249 @default.
• W2080681938 cites W1923449517 @default.
• W2080681938 cites W1946638503 @default.
• W2080681938 cites W1989724007 @default.
• W2080681938 cites W1994506041 @default.
• W2080681938 cites W1997472682 @default.
• W2080681938 cites W2004420675 @default.
• W2080681938 cites W2013019516 @default.
• W2080681938 cites W2025008300 @default.
• W2080681938 cites W2034195171 @default.
• W2080681938 cites W2047637145 @default.
• W2080681938 cites W2080891890 @default.
• W2080681938 cites W2087256498 @default.
• W2080681938 cites W2104367773 @default.
• W2080681938 cites W2124061625 @default.
• W2080681938 cites W2406995556 @default.
• W2080681938 cites W2417955256 @default.
• W2080681938 doi "https://doi.org/10.1159/000076458" @default.
• W2080681938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15004486" @default.
• W2080681938 hasPublicationYear "2003" @default.
• W2080681938 type Work @default.
• W2080681938 sameAs 2080681938 @default.
• W2080681938 citedByCount "15" @default.
• W2080681938 countsByYear W20806819382014 @default.
• W2080681938 countsByYear W20806819382015 @default.
• W2080681938 crossrefType "journal-article" @default.
• W2080681938 hasAuthorship W2080681938A5030190878 @default.
• W2080681938 hasAuthorship W2080681938A5056157710 @default.
• W2080681938 hasAuthorship W2080681938A5074072927 @default.
• W2080681938 hasAuthorship W2080681938A5081012227 @default.
• W2080681938 hasConcept C118646709 @default.
• W2080681938 hasConcept C121608353 @default.
• W2080681938 hasConcept C126322002 @default.
• W2080681938 hasConcept C126838900 @default.
• W2080681938 hasConcept C2776049877 @default.
• W2080681938 hasConcept C2777387746 @default.
• W2080681938 hasConcept C2779902710 @default.
• W2080681938 hasConcept C530470458 @default.
• W2080681938 hasConcept C71924100 @default.
• W2080681938 hasConceptScore W2080681938C118646709 @default.
• W2080681938 hasConceptScore W2080681938C121608353 @default.
• W2080681938 hasConceptScore W2080681938C126322002 @default.
• W2080681938 hasConceptScore W2080681938C126838900 @default.
• W2080681938 hasConceptScore W2080681938C2776049877 @default.
• W2080681938 hasConceptScore W2080681938C2777387746 @default.
• W2080681938 hasConceptScore W2080681938C2779902710 @default.
• W2080681938 hasConceptScore W2080681938C530470458 @default.
• W2080681938 hasConceptScore W2080681938C71924100 @default.
• W2080681938 hasIssue "6" @default.
• W2080681938 hasLocation W20806819381 @default.
• W2080681938 hasLocation W20806819382 @default.
• W2080681938 hasOpenAccess W2080681938 @default.
• W2080681938 hasPrimaryLocation W20806819381 @default.
• W2080681938 hasRelatedWork W1863700672 @default.
• W2080681938 hasRelatedWork W1895410565 @default.
• W2080681938 hasRelatedWork W2017898920 @default.
• W2080681938 hasRelatedWork W2080681938 @default.
• W2080681938 hasRelatedWork W2118125095 @default.
• W2080681938 hasRelatedWork W2139425553 @default.
• W2080681938 hasRelatedWork W2384739398 @default.
• W2080681938 hasRelatedWork W2416148511 @default.
• W2080681938 hasRelatedWork W2513966554 @default.
• W2080681938 hasRelatedWork W3029946366 @default.
• W2080681938 hasVolume "24" @default.
• W2080681938 isParatext "false" @default.
• W2080681938 isRetracted "false" @default.
• W2080681938 magId "2080681938" @default.
• W2080681938 workType "article" @default.